DOCGO INC (DCGO) Stock Fundamental Analysis
USA - NASDAQ:DCGO - US2560861096 - Common Stock
1.03 USD
-0.06 (-5.5%)
DCGO gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 100 industry peers in the Health Care Providers & Services industry. While DCGO has a great health rating, there are worries on its profitability. DCGO has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
DCGO had negative earnings in the past year.
In the past year DCGO had a positive cash flow from operations.
DCGO had positive earnings in 4 of the past 5 years.
In multiple years DCGO reported negative operating cash flow during the last 5 years.
1.2 Ratios
With a Return On Assets value of -4.49%, DCGO is not doing good in the industry: 67.00% of the companies in the same industry are doing better.
The Return On Equity of DCGO (-6.16%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.49% | ||
| ROE | -6.16% | ||
| ROIC | N/A |
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
DCGO's Profit Margin has declined in the last couple of years.
DCGO's Operating Margin has declined in the last couple of years.
The Gross Margin of DCGO (33.65%) is better than 63.00% of its industry peers.
In the last couple of years the Gross Margin of DCGO has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for DCGO so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 33.65% |
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
2. Health
2.1 Basic Checks
DCGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DCGO has less shares outstanding
Compared to 1 year ago, DCGO has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.74, we must say that DCGO is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.74, DCGO is doing worse than 61.00% of the companies in the same industry.
DCGO has a debt to FCF ratio of 0.58. This is a very positive value and a sign of high solvency as it would only need 0.58 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.58, DCGO belongs to the best of the industry, outperforming 92.00% of the companies in the same industry.
A Debt/Equity ratio of 0.14 indicates that DCGO is not too dependend on debt financing.
DCGO's Debt to Equity ratio of 0.14 is fine compared to the rest of the industry. DCGO outperforms 73.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | 0.58 | ||
| Altman-Z | 1.74 |
ROIC/WACCN/A
WACC8.88%
2.3 Liquidity
A Current Ratio of 2.36 indicates that DCGO has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.36, DCGO belongs to the best of the industry, outperforming 81.00% of the companies in the same industry.
DCGO has a Quick Ratio of 2.36. This indicates that DCGO is financially healthy and has no problem in meeting its short term obligations.
DCGO has a better Quick ratio (2.36) than 82.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.36 | ||
| Quick Ratio | 2.36 |
3. Growth
3.1 Past
DCGO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -137.93%.
The Earnings Per Share has been decreasing by -9.93% on average over the past years.
The Revenue for DCGO has decreased by -41.31% in the past year. This is quite bad
The Revenue has been growing by 24.60% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-137.93%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-257.14%
Revenue 1Y (TTM)-41.31%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-51.25%
3.2 Future
Based on estimates for the next years, DCGO will show a very negative growth in Earnings Per Share. The EPS will decrease by -39.69% on average per year.
The Revenue is expected to decrease by -17.73% on average over the next years. This is quite bad
EPS Next Y-274.18%
EPS Next 2Y-63.99%
EPS Next 3Y-39.69%
EPS Next 5YN/A
Revenue Next Year-49.13%
Revenue Next 2Y-28.84%
Revenue Next 3Y-17.73%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
DCGO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year DCGO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
100.00% of the companies in the same industry are more expensive than DCGO, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1.24 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
DCGO's earnings are expected to decrease with -39.69% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-63.99%
EPS Next 3Y-39.69%
5. Dividend
5.1 Amount
No dividends for DCGO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:DCGO (11/3/2025, 1:39:22 PM)
1.03
-0.06 (-5.5%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners52.39%
Inst Owner Change-0.3%
Ins Owners7.1%
Ins Owner Change0.95%
Market Cap100.74M
Revenue(TTM)435.97M
Net Income(TTM)-18325500
Analysts78.46
Price Target3.14 (204.85%)
Short Float %4.68%
Short Ratio2.31
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-163.06%
Min EPS beat(2)-311.74%
Max EPS beat(2)-14.37%
EPS beat(4)1
Avg EPS beat(4)-86.11%
Min EPS beat(4)-311.74%
Max EPS beat(4)0.93%
EPS beat(8)2
Avg EPS beat(8)-48.05%
EPS beat(12)3
Avg EPS beat(12)-63.61%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-4.02%
Min Revenue beat(2)-9.68%
Max Revenue beat(2)1.64%
Revenue beat(4)1
Avg Revenue beat(4)-4.48%
Min Revenue beat(4)-9.68%
Max Revenue beat(4)1.64%
Revenue beat(8)4
Avg Revenue beat(8)0.77%
Revenue beat(12)7
Avg Revenue beat(12)1.29%
Revenue beat(16)10
Avg Revenue beat(16)9.13%
PT rev (1m)0%
PT rev (3m)0.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-87.93%
EPS NY rev (1m)0%
EPS NY rev (3m)-30.59%
Revenue NQ rev (1m)-0.29%
Revenue NQ rev (3m)2.06%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.23 | ||
| P/FCF | 1.24 | ||
| P/OCF | 1.16 | ||
| P/B | 0.34 | ||
| P/tB | 0.46 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.11
EYN/A
EPS(NY)-0.18
Fwd EYN/A
FCF(TTM)0.83
FCFY80.72%
OCF(TTM)0.89
OCFY86.54%
SpS4.46
BVpS3.04
TBVpS2.26
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.49% | ||
| ROE | -6.16% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 33.65% | ||
| FCFM | 18.65% |
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.11%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
F-Score5
Asset Turnover1.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | 0.58 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 38.46% | ||
| Cap/Sales | 1.34% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.36 | ||
| Quick Ratio | 2.36 | ||
| Altman-Z | 1.74 |
F-Score5
WACC8.88%
ROIC/WACCN/A
Cap/Depr(3y)50.15%
Cap/Depr(5y)71.98%
Cap/Sales(3y)1.27%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-137.93%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-257.14%
EPS Next Y-274.18%
EPS Next 2Y-63.99%
EPS Next 3Y-39.69%
EPS Next 5YN/A
Revenue 1Y (TTM)-41.31%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-51.25%
Revenue Next Year-49.13%
Revenue Next 2Y-28.84%
Revenue Next 3Y-17.73%
Revenue Next 5YN/A
EBIT growth 1Y-153.15%
EBIT growth 3Y14.13%
EBIT growth 5YN/A
EBIT Next Year-159.15%
EBIT Next 3Y-57.49%
EBIT Next 5YN/A
FCF growth 1Y457.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y734.5%
OCF growth 3YN/A
OCF growth 5YN/A
DOCGO INC / DCGO FAQ
What is the fundamental rating for DCGO stock?
ChartMill assigns a fundamental rating of 3 / 10 to DCGO.
Can you provide the valuation status for DOCGO INC?
ChartMill assigns a valuation rating of 2 / 10 to DOCGO INC (DCGO). This can be considered as Overvalued.
How profitable is DOCGO INC (DCGO) stock?
DOCGO INC (DCGO) has a profitability rating of 2 / 10.
Can you provide the expected EPS growth for DCGO stock?
The Earnings per Share (EPS) of DOCGO INC (DCGO) is expected to decline by -274.18% in the next year.